Drugs and Therapy Studies is a new, online-only, international, Open Access peer-reviewed journal which publish research papers in all areas of preclinical and clinical pharmacology and therapies for human diseases from drug synthesis and/or discovery to advanced clinical trials It is also open to any human disease and not restricted to a particular pathology. Drugs and Therapy Studies publish original articles (short communication and full articles), reviews, mini-reviews, editorials, case reports, and letters to the editor, news and commentaries.
Drugs and Therapy Studies offers fast peer-review and publication. Corresponding authors will receive a notification within 72 hrs that his/her manuscript is accepted or not for revision. All original articles submitted to this journal that has not been previously rejected by other journal should be prepared according our journal style and will be reviewed within one month. Manuscript rejected by other journals can be submitted to Drugs and Therapy Studies in other formats with a detailed response to the critiques. These articles will be ultra-fast peer-reviewed and decisions will be made within 3-4 weeks. In case the paper is accepted, author will need to change the style according to our journal style.
Vol 3, No 1 (2013)
Table of Contents
|Evaluations about the physico-chemical stability of docetaxel and irinotecan pre-diluted and diluted solutions: pharmaco-economic perspectives|
|Mariarita Laforgia, Anna Elisa Quatrale, Nicola A. Colabufo, Amalia Azzariti, Angelo Paradiso, Patrizia Nardulli | Published: 2013-10-16 14:41:55 | DOI: 10.4081/dts.2013.e6 | Abstract views: 724||e6|
|Guinea-pig ileum as ex vivo model useful to characterize ligands displaying Imidazoline I2 and Adrenergic alpha2 mixed activity: a preliminary study|
|Marialessandra Contino, Antonio Carrieri, Francesco Berardi, Marcello Leopoldo, Roberto Perrone, Russell Thomas, Nicola Antonio Colabufo | Published: 2013-01-22 10:16:43 | DOI: 10.4081/dts.2013.e1 | Abstract views: 1886||e1|
|Formulation, development and evaluation of injectable formulation of Aspirin|
|Rakesh P. Patel, Kaushal P. Patel, Kushal A. Modi, Chirayu J. Pathak | Published: 2013-07-01 15:20:11 | DOI: 10.4081/dts.2013.e2 | Abstract views: 1905||e2|
|Development of a drug safety ePlatform for physicians, pharmacists, and consumers based on post-marketing adverse events|
|Keith B. Hoffman, Brian M. Overstreet, P. Murali Doraiswamy | Published: 2013-07-10 17:02:26 | DOI: 10.4081/dts.2013.e4 | Abstract views: 1657||e4|
|Exploring prospects of β3-adrenoceptor agonists and inverse agonists for colon mobility control|
|Maria Grazia Perrone, Marialessandra Contino, Antonio Scilimati | Published: 2013-07-03 10:21:23 | DOI: 10.4081/dts.2013.e5 | Abstract views: 1569||e5|
|From big data to bedside decision-making: the case for AdverseEvents|
|Giuseppe Biondi Zoccai, Elena Cavarretta, Giacomo Frati | Published: 2013-07-01 15:38:33 | DOI: 10.4081/dts.2013.e3 | Abstract views: 1789||e3|
This work is licensed under a Creative Commons Attribution 3.0 License.
Drugs and Therapy Studies [eISSN 2038-9507] is an Open Access, peer-reviewed journal published by PAGEPress, Pavia, Italy. All credits and honors to PKP for their OJS.